7 %A review and meta-analysis study of COVID-19 patients in April 2020 revealed bacterial co-infections in 7% of hospitalized patients.
NigeriaCOVID-19observed April 2020HAL · Unilimdocument of 63 observations
Gold tier: mechanically validated evidence, with its primary source.
209 evidence items · page 9 / 9
7 %A review and meta-analysis study of COVID-19 patients in April 2020 revealed bacterial co-infections in 7% of hospitalized patients.
NigeriaCOVID-19observed April 2020HAL · Unilimdocument of 63 observations
7.15 daysThe mean recovery time from symptom onset was 7.15 days for COVID-19 patients treated with ivermectin.
NigeriaCOVID-19published 2022West African journal of medicinePubMeddocument of 2 observations
50 %More than 50% of mild and moderate COVID-19 cases received antimicrobial prescription.
NigeriaCOVID-19HAL · Unilimdocument of 63 observations
22.2 %Moderna was the second most administered COVID-19 vaccine, accounting for 22.2% of doses.
NigeriaCOVID-19observed April-June 2024published 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 8 observations
9.07 per_1000_person_daysThe mortality rate was 9.07 per thousand person-days among patients with COVID-19 admitted to a tertiary referral hospital in Lagos, Nigeria.
NigeriaCOVID-19published 2023Nigerian journal of clinical practicePubMeddocument of 6 observations
95 %95% of the participants believed SARS-CoV-2 infection is a viral infection.
NigeriaCOVID-19published 2022Nigerian journal of clinical practicePubMeddocument of 9 observations
67.5 %Among RT-PCR-negative patients, 67.5% were symptomatic, compared to 44.6% among RT-PCR-positive patients.
NigeriaCOVID-19observed 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations
33.7 %Cough was present in 33.7% of RT-PCR-negative patients and 23.1% of RT-PCR-positive patients.
NigeriaCOVID-19observed 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations
0.43 aORUse of a face mask was associated with decreased odds of SARS-CoV-2 infection (adjusted odds ratio 0.43, 95% CI: 0.19–0.95).
NigeriaCOVID-19observed April to July 2020published 2022The Pan African medical journalPubMeddocument of 13 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.